baber/WOPTO huggingface dataset:
Patent CA-2663467-A1 (CA)
Title: Fuel cell, fuel cell stack, and fuel cell apparatus
Inventor: HORI YUUICHI
IPC: H01M8/12
Filed: 2007-08-24
Abstract: Provided is a fuel battery cell which prevents reaction between a component contained in a solid electrolyte and an oxygen side electrode during a long period of operation, so as to improve the durability. A fuel battery cell stack and a fuel battery using the fuel battery cell are also provided. The fuel battery cell (10) includes an intermediate layer (4) and an oxygen side electrode (1) on one of the surfaces of a solid electrolyte (9) containing Zr and a fuel side electrode (7) on the other surface of the solid electrolyte (9) opposing to the oxygen side electrode (1). The intermediate layer (4) has a surface region (4a) of the solid electrolyte (9) side containing Zr and a region (4b) other than the surface layer (4a) not containing Zr. Accordingly, it is possible to suppress the reaction between Zr and the oxygen side electrode (1) and suppress degradation of the generation performance of the fuel battery cell (10).
Patent CA-2665376-A1 (CA)
Inventor: PUIG DURAN CARLOS
IPC: A61P9/00
Filed: 2007-10-17
Abstract: The present invention provides a Compound of formula (I), wherein: R1 is a group selected from -CH2OH,-NH(CO)H; and R2 is a hydrogen atom; or R1 together with R2 form the group -NH-C(O)-CH=CH-, wherein the nitrogen atom is bound to the carbon atom in the phenyl ring holding R1 and the carbon atom is bound to the carbon atom in the phenyl ring holding R2;R3a and R3b are independently selected from the group consisting of hydrogen atoms and C1-4 alkyl groups; X and Y are independently selected from the group consisting of direct bond and oxygen atom; n, m and q each independently has a value selected from 0, 1, 2 and 3; p has a value selected from 1, 2 and 3; R4 and R5 are independently selected from hydrogen atoms, halogen atoms, C1-4 alkyl, C1-4 alkoxy, -CONH2, -NHCONH2, -SR7, -SOR7, -SO2R7, -SO2NHR8 and the groups (a) and (b), wherein R7 is selected from C1-4alkyl and C3-8 cycloalkyl and R8 is selected from hydrogen atoms and C1-4alkyl groups; R6 is selected from the group consisting of hydrogen atoms, halogen atoms, C1-4 alkyl and C1-4 alkoxy or a pharmaceutically-acceptable salt, solvate or stereoisomer thereof.
Patent CA-2667194-A1 (CA)
Title: System and method for scalable video coding using telescopic mode flags
Inventor: HONG DANNY
IPC: H04N7/18
Filed: 2007-10-23
Abstract: Systems and methods for scalable video coding using special inter-layer prediction modes (called telescopic modes) are provided. These modes facilitate accelerated operation of encoders with improved coding efficiency.
Patent CA-2669701-A1 (CA)
Inventor: BARRY STEPHEN
IPC: A47C31/11
Filed: 2009-06-23
Abstract: The present invention provides a self-fitting slip cover configured to fit various sized seat cushions having a top surface, a bottom surface, opposed side surfaces, and opposed end surfaces. The self-fitting slip cover comprises a resilient fabric pouch comprising an expandable, opening adapted for receiving the seat cushion, and an elastic band extending along the peripheral edge of the opening of the resilient fabric pouch; said elastic band having an unstretched state and a stretched state. The resilient fabric pouch is sized and configured to tautly cover the top surface, opposed side surface and opposed end surfaces of the seat cushion and a portion of said bottom surface of the seat cushion when the seat cushion is received in the slip cover and the elastic band is in the stretched state.
Patent CA-2676954-A1 (CA)
Inventor: FIORASO-CARTIER LAETICIA
IPC: A61K31/437
Filed: 2008-03-20
Abstract: The present invention is related to pyrazolopyridine derivatives of Formula (I) as depicted below, wherein the groups G1 -G5 are as disclosed herein, pharmaceutical composition thereof, and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase). (see above formula)
Patent CA-2678031-A1 (CA)
Title: Generator power plant protection system and method
Inventor: ASPIN JASON CONRAD
IPC: H02J3/38
Filed: 2008-02-15
Abstract: A typical power plant has a plurality of generators; at least one load; at least one bus interconnecting the generators and the at least one load. The plant is operated on an uncorrected droop configuration for speed control and voltage control. The plant further includes a monitoring module for monitoring at least one of a plurality of signals; a calculating module for calculating a fault based on a comparison of predefined values expected from normal droop operation with respect to monitored values obtained from the monitored signals; and a control module for providing an order to bring additional generating capacity on line, for tripping a generator if a fault has been identified with respect to a single generator or for tripping a tie breaker to provide bus to bus isolation if an identified fault cannot be isolated to a single generator.
Patent CA-2679010-A1 (CA)
Title: Pellets comprising an active substance matrix resistant to gastric juice
Inventor: GRYCZKE ANDREAS
IPC: A23L33/00
Filed: 2008-01-08
Abstract: The invention relates to pellets having a mean particle size of between 300 and 1100 µm, containing a pharmaceutically active substance integrated into a polymer matrix consisting of at least one water-insoluble polymer. The invention is characterised in that the polymer matrix also contains between 10 and 90 wt. % of an anionic polymer, in the release test according to USP, provided that the pellets release no more than 10 % of the active substance in the artificial gastric juice at a pH of 1.2 after 120 min, and release at least 50 % of the active substance after a total of another 300 min at a pH of 6.8 and/or 7.5.
Patent CA-2679872-A1 (CA)
Title: Corrosion inhibiting compositions comprising unsaturated aldehydes, sulfur compounds, and nitrogen based surfactants
Inventor: WELTON THOMAS D
IPC: C09K8/72
Filed: 2008-03-11
Abstract: Corrosion-inhibiting additives comprising certain surfactants, and associated treatment fluids and methods of use are described. In one embodiment, the method comprises: providing a treatment fluid that comprises a base fluid, an .alpha.,.beta.-unsaturated aldehyde, a sulfur-containing compound, and at least one nitrogen-containing surfactant that is anionic, nonionic, amphoteric, or zwitterionic; and introducing the treatment fluid into a subterranean formation. In another embodiment, the method comprises: providing a corrosion-inhibiting additive that comprises an .alpha.,.beta.-unsaturated aldehyde, a sulfur-containing compound, and at least one nitrogen-containing surfactant that is anionic, nonionic, amphoteric, or zwitterionic; contacting a surface with the corrosion-inhibiting additive; and allowing the corrosion- inhibiting additive to interact with the surface, whereby corrosion of the surface is at least partially inhibited or a portion of an undesirable substance on the surface is removed.
Patent CA-2680421-A1 (CA)
Inventor: MILLER THOMAS
IPC: F42C19/08
Filed: 2008-03-14
Abstract: A detonator free blasting system, which comprises: a bulk explosive; a confined explosive; a fiber optic adapted to deliver laser light to the confined explosive, wherein the confined explosive is provided relative to the bulk explosive such that detonation of the confined explosive causes initiation of the bulk explosive.
Patent CA-2682209-A1 (CA)
Inventor: MAYR WINFRIED
IPC: A61N1/372
Filed: 2008-03-20
Abstract: The invention relates to a system (1) for electrically stimulating muscles, in particular denervated muscles (M), or nerves, comprising a stimulator (2) for generating electrical pulses, said stimulator being connected to a unit (4) for the supply of electric energy and for control purposes and comprising at least two electrodes (3) that are connected to the stimulator (2) and that emit electric pulses to the muscles (M) or nerves. The aim of the invention is to produce a stimulation system (1) of this type which improves safety, selectivity and is easier to use. To achieve this, the stimulator (2) and at least two electrodes (3) are designed to be implanted, at least one electrode (3) being designed to be fixed to a bone (K). The functional electric stimulation can thus be used in particular for the prevention of decubitus.
Patent CA-2683336-A1 (CA)
Inventor: HAUGEBERG BRYAN
IPC: F16H48/12
Filed: 2009-10-22
Abstract: A clutch assembly for a locking differential includes driving clutch members engaged with driven clutch members in a preloaded configuration to provide a minimum amount of preload there between during low torque conditions. The driving clutch members are biased relative to each other with shear pin/spring assemblies located within bores of the driving clutch members. During assembly of the clutch assembly, the shear pin/spring assemblies may be positively locked down within the bores with a removable tool. In one embodiment, the removable tool is inserted into a small opening extending through the driving clutch member and the tool engages an annular groove on a shear pin of the shear pin/spring assembly. Further, the clutch assembly may include driving clutch members having drainage openings that may help prevent hydraulic lock during operation of the locking differential.
Patent CA-2686312-A1 (CA)
Inventor: CHEN WEIYU
IPC: A61K31/565
Filed: 2008-05-01
Abstract: A process of making an aromatase inhibitor of formula (I) : wherein each of R1, R2, R3, and R4, independently, is hydrogen, halogen, or C1-C6 alkyl, comprising reacting a compound of formula (II) : with an acid in the presence of a suitable solvent. A new crystalline form of exemestane and is also disclosed.
Patent CA-2687787-A1 (CA)
Inventor: MASER RICHARD
IPC: A01K67/033
Filed: 2008-05-21
Abstract: The present invention features transgenic non-human mammalian animals being genetically modified to develop cancer. The invention also relates to methods for identifying genes or genetic elements that are potentially related to human cancers using an chromosomally unstable animal model. Information on such genetic alterations can be used to predict cancer therapeutic outcomes and to stratify patient populations to maximize therapeutic efficacy.
Patent CA-2688315-A1 (CA)
Inventor: KITAMURA HIROYASU
IPC: H02J7/00
Filed: 2009-12-14
Abstract: A driving circuit drives a switching element such that an ON-period of the switching element is shorter when a power receiving device is detected not to be placed than when the power receiving device is placed.
Patent CA-2692143-A1 (CA)
Inventor: AJJI ABDELLAH
IPC: A61F2/06
Filed: 2008-05-21
Abstract: A mat having a highly uniform porosity distribution is produced by consolidating 15 or more layers of melt blown webs (or the like) having different orientations. Control over the porosity is provided by using webs that exhibit a narrow, unimodal distribution of fiber diameters over the bulk of its distribution, such as in the top 80%. A compliance of the mats can be chosen by selecting a number and orientation of the webs. It is thus possible to produce mats that are good candidates for vascular grafts, for example. The uniformity of the porosity within the range of 6 µm to 30 µm permits seeding of the vascular graft with endothelial and smooth muscle cells. The mats have the demonstrated ability to retain, and support growth of, smooth muscle cells. The mats have the demonstrated ability to retain, and support growth of, smooth muscle cells and endothelial cells.
Patent CA-2692419-A1 (CA)
Title: Inhibitors of polysialic acid de-n-acetylase and methods for using the same
Inventor: MOE GREGORY R
IPC: A01N43/04
Filed: 2008-07-03
Abstract: The invention relates to inhibitors of polysialic (PSA) de-N-acetylase, methods of their production and use. The methods involve use of a PSA de-N-acetylase inhibitor for modifying the growth of cells, such as inhibiting the growth of cancer cells. The compositions include an inhibitor of a PSA de-N-acetylase, such as N-substituted derivatives of the amino sugars hexosamine and neuraminic acid, as well as conjugates and aggregates. Also provided are pharmaceutical compositions that include a PSA de-N-acetylase inhibitor of the invention. Kits containing one or more inhibitor compositions of the invention, as well as methods of preparing the compositions also are provided.
Patent CA-2693220-A1 (CA)
Inventor: MULLER ERWIN
IPC: G05B19/042
Filed: 2008-05-29
Abstract: The invention relates to a device for inserting, collecting or collating a plurality of flexible, planar products, preferably printed products, wherein the device (10, 10a, 10b) comprises a product collection unit (12, 12a), a first processing unit (14, 14'), and a second processing unit (16, 16', 16') for the synchronized processing, for example feeding, of products. The product collection unit (14, 14') comprises a main drive controller (18), which is operatively connected to a main drive (20, 20') for driving a conveying means (22). The first processing unit (14, 14') comprises a first drive controller (24, 24'), which is operatively connected to a first drive (26, 26', 26'), and the second processing unit (16, 16', 16') comprises a second drive controller (28, 28', 28'), which is operatively connected to a second drive (30, 30'). The first processing unit (14, 14') additionally comprises a first data collector (34, 34'), which is connected to the main drive controller (18) and to the first drive controller (24, 24') via a first data bus (32, 32'), while the second processing unit (16, 16', 16') comprises a second data collector (36, 36'), which is connected to the first drive controller (24, 24') and the second drive controller (28) via the first data bus (32, 32').
Patent CA-2693661-A1 (CA)
Inventor: LAMBARTH CLIFF
IPC: A61G3/02
Filed: 2008-06-25
Abstract: A patient support includes a base, a patient support surface supported by the base, an electrically powered device, and a rechargeable power storage device for powering the electrically powered device. Further, the patient support includes a receiving coil that is electrically coupled to the rechargeable power supply for inductive coupling with a transmitting coil, the receiving coil for recharging the rechargeable power supply when the receiving coil is inductively coupled to the transmitting coil.
Patent CA-2693662-A1 (CA)
Inventor: ROTBART ASSI
IPC: H04M7/00
Filed: 2008-07-08
Abstract: A method and system for initiating a connection between at least a first communication device and a second communication device respective of a first party and a second party. According to the present invention initiating a connection includes obtaining a destination subscriber identifier from the first party, wherein the destination subscriber identifier is a string including at least one character different than a numeric character and is respective of the second party. Then, a resolution request that includes data indicative of the destination subscriber identifier is conveyed to a hosting information storage server respective of the destination subscriber identifier, a resolution response including a destination address respective of the second communication device wherein the second party is available is obtained, and then, the present invention includes initiating a connection between the first communication device and the second communication device.
Patent CA-2698082-A1 (CA)
Inventor: SALINGER JORGE DANIEL
IPC: H04L12/26
Filed: 2010-03-30
Abstract: A subscriber network architecture includes a packet processing node that communicates with a network backbone and with a plurality of access nodes. The access nodes communicate with a plurality of user devices. The packet processing node controls Quality of Service (QoS) levels for the subscriber devices, routes user data to devices via the access nodes and receives data from devices via the access nodes for forwarding across the network backbone.
Patent CA-2699296-A1 (CA)
Inventor: STREEPER ROBERT T
IPC: G01N30/06
Filed: 2008-09-11
Abstract: A method of identifying proteins present in human serum which are differentially expressed between normal individuals and patients known to have non-small cell lung cancers and asthma, as diagnosed by a physician. Human serum specimens from each population are digested with trypsin or any other suitable endoproteinase and analyzed using a liquid chromatography electrospray ionization mass spectrometer. Mass spectral data from each population is compared to determine proteins with expression intensities which are significantly differentially expressed between the normal, asthma, and lung cancer populations. Eleven proteins are found to have expression intensities which are significantly differentially expressed between the populations. Finally, the identity of the eleven proteins are obtained by comparing the mass spectral data with known databases having libraries of mass spectral data of known proteins.
Patent CA-2699799-A1 (CA)
Title: Cable autoregulant a comportement ctp et a puissance electrique modulable, son connecteur, un dispositif les comprenant et utilisation de ce dernier
Inventor: PAUL BERT PHILIPPE
IPC: H05B3/06
Filed: 2008-09-10
Abstract: La présente invention porte sur un câble autorégulant à comportement CTP et à puissance électrique modulable, son connecteur spécifique, un dispositif comprenant ledit câble et ledit connecteur ainsi que l'utilisation de ce dispositif pour générer une puissance électrique modulable à partir d'un câble unique.
Patent CA-2700364-A1 (CA)
Title: Method for creating perfusable microvessel systems
Inventor: NEUMANN THOMAS
IPC: C12N11/00
Filed: 2008-09-11
Abstract: A method for creating networks of perfusable microvessels (222) in vitro. A  mandrel (916) is drawn through a matrix (1054) to form a channel through the matrix (1010). Cells (1) are injected into the channel (1014). The matrix (1054) is incubated to allow the cells (1) to attach inside the channel (1016). The channel is perfused (1020) to remove unattached cells to create a parent vessel (1022), where the parent vessel (1102) includes a perfusable hollow channel lined with cells (1) in the matrix (1054). The parent vessel (1102) is induced to create sprouts (1106) into the surrounding matrix gel (1054) so as to form a microvessel network (222). The microvessel network (222) is subjected to luminal perfusion through the parent vessel (1102).
Patent CA-2701589-A1 (CA)
Inventor: SCOTTI ALBERTO
IPC: F04D15/00
Filed: 2010-04-22
Abstract: A system is described, for recovering energy in a gas compression plant comprising: at least one centrifugal compressor (10) capable of sucking the gas, at a certain inlet pressure, from a suction conduit (14) and of delivering the gas, at a certain outlet pressure that is greater than such an inlet pressure, through a delivery conduit (16); at least one gas recirculation system (A;  B) capable of redirecting the gas from the delivery conduit (16) to the suction conduit (14) when the gas flow rate entering into the compressor (10) is below a certain limit value. In the portion of the plant arranged downstream of the compressor (10) at least one turbo--expander (36; 46) and at least one valve (24; 33) are installed in parallel that cooperate with each other and that are controlled by electronic devices (35) so as to protect the compressor (10) and at the same time to produce useful energy during recirculation mode.
Patent CA-2703317-A1 (CA)
Inventor: PEREZ ORLANDO G
IPC: F28D7/00
Filed: 2010-05-06
Abstract: A process for exchanging heat in a shell and tube gas-to-gas heat exchanger between a plurality of gases, said process comprising passing a cold first gas in parallel flow to a second hot gas to provide a warmer first gas; and passing said warmer first gas in counter-current flow to a hot third gas to provide a cooler said third gas. The invention provides increased minimum tube wall temperature within the exchanger for given process conditions while maintaining a high log mean temperature differential allowing for the prevention of corrosion from entrained corrosive vapours or entrained corrosive mist with a minimal increase in effective area.
Patent CA-2703951-A1 (CA)
Title: Use and production of neutral metalloproteases in a serine protease-free background
Inventor: LEE EDWIN
IPC: C12N9/54
Filed: 2008-10-06
Abstract: The present invention provides methods and compositions comprising at least one neutral metalloprotease enzyme in the relative absence of serine protease enzyme contaminants. In some embodiments, the neutral metalloprotease finds use in cleaning and other applications. In some particularly preferred embodiments, the present invention provides methods and compositions comprising Bacillus strains engineered to be deficient in multiple serine proteases, and their use in production of recombinant neutral metalloprotease(s).
Patent CA-2706599-A1 (CA)
Inventor: CRESPO JAVIER
IPC: A23L27/00
Filed: 2008-11-27
Abstract: The invention relates to compositions comprising aromatic substances contained in pig milk and their use to increase piglet appetite.
Patent CA-2706614-A1 (CA)
Title: Fluoroalkyl silanes
Inventor: HERZOG AXEL HANS-JOACHIM
IPC: C07F7/18
Filed: 2008-12-01
Abstract: Fluoroalkyl silanes are a class of compounds useful for various industrial purposes. For example, fluoroalkyl silanes which have hydrolysable groups (called hydrolysable fluoroalkyl silanes), are compounds useful as surface treatment agents which provide durable hydrophobic and oleophobic coatings. In general, hydrolysable fluoroalkyl silanes can be represented with the following formula: (RO-)sSi-Rt wherein R is H or an alkyl; and RT is a monovalent organic compound terminated by a perfluoroalkyl group. When used to coat a surface, the (RO-)3 moiety reacts (via hydrolysis) with various chemical groups of the surface (e.g., hydroxyl, amine, or other reactive groups) thereby bonding the fluoroalkyl silane to the surface The RT moiety comprises a divalent organic linking group which links the silicon atom to a terminal group rich in fluorine atoms whose unique electronic properties impart desirable hydrophobic and oleophobic properties in a surface coating. Modification of the RT moiety is useful in the engineering of fluoroalkyl silanes. The present invention provides for fluoroalkyl silanes having Rt moieties which have not been heretofore considered.
Patent CA-2709286-A1 (CA)
Title: Dispenser having internal spring actuation
Inventor: GIRAUD JEAN-PIERRE
IPC: B65D83/04
Filed: 2008-12-10
Abstract: A dispenser is disclosed for dispensing a single object at a time, such as a tablet or the like. The dispenser includes a reservoir to contain tablets and an opening in the reservoir sized to pass the tablets. A chute is defined by a wall adjacent to the opening in the reservoir, and defines a dispensing path. The movable dispensing guide has a retracted position that does not prevent the advance of tablets along the dispensing path, and an advanced position that intersects the dispensing path between the first and second tablets in the dispensing path. When advanced, the movable dispensing guide allows the first tablet in line to be dispensed from the path, and prevents the second tablet in line from advancing. The actuator is operable to move the movable dispensing guide from its retracted position to its advanced position.